Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(5), P. 629 - 629
Published: April 26, 2025
Background/Objectives:
Alzheimer’s
disease
(AD)
is
the
most
common
type
of
dementia,
characterized
by
complex
processes
such
as
neuro-inflammation,
oxidative
damage,
synaptic
loss,
and
neuronal
death.
Carotenoids
are
among
potential
therapeutic
molecules
that
have
attracted
attention
due
to
their
neuroprotective
properties,
but
efficacy
limited
mainly
capacity
cross
blood–brain
barrier
(BBB).
Results:
The
results
showed
T.
chuii
extracts
could
protect
cells
from
neurotoxic
especially
against
L-glutamate
H2O2.
Moreover,
BBB
permeability
intestinal
transport
analyses
revealed
fucoxanthinol,
crocoxanthin,
diatoxanthin,
neoxanthin,
violaxanthin,
prasinoxanthin
diverse
permeabilities
depending
on
incubation
time
cell
model
used.
Fucoxanthinol
was
carotenoid
with
highest
similar
in
HBMEC
(4.41%,
5.13%,
18.94%
at
2,
4,
24
h,
respectively)
Caco-2
(7.01%,
8.63%,
18.36%
same
times),
while
neoxanthin
different
kinetics.
Methods:
two
obtained
Tetraselmis
microalga
were
evaluated
Aβ1-42-,
L-glutamate-,
H2O2-induced
toxicities
SH-SY5Y
cells.
In
addition,
transepithelial
main
carotenoids
present
compared
using
culture
models,
For
aim,
bioactive
across
barriers
UHPLC-q-TOF-MS
after
h
incubation.
Conclusions:
These
findings
indicate
a
promising
natural
source
compounds
develop
functional
foods
neurodegenerative
diseases.
Neural Plasticity,
Journal Year:
2021,
Volume and Issue:
2021, P. 1 - 10
Published: Dec. 6, 2021
The
blood-brain
barrier
(BBB)
is
a
semipermeable
and
extremely
selective
system
in
the
central
nervous
of
most
vertebrates,
that
separates
blood
from
brain's
extracellular
fluid.
It
plays
vital
role
regulating
transport
necessary
materials
for
brain
function,
furthermore,
protecting
it
foreign
substances
could
damage
it.
In
this
review,
we
searched
Google
Scholar,
Pubmed,
Web
Science,
Saudi
Digital
Library
various
cells
components
support
development
function
barrier,
as
well
different
pathways
to
molecules
between
brain.
We
also
discussed
aspects
lead
BBB
dysfunction
its
neuropathological
consequences,
with
identification
some
important
biomarkers
might
be
used
biomarker
predict
disturbances.
This
comprehensive
overview
will
pave
way
future
studies
focus
on
developing
more
specific
targeting
systems
material
delivery
approach
assists
combinatorial
therapy
or
nanotherapy
destroy
modify
pathological
conditions
such
tumors
stem
cell
carcinomas.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
35(32)
Published: April 26, 2023
Major
challenges
in
biofabrication
revolve
around
capturing
the
complex,
hierarchical
composition
of
native
tissues.
However,
individual
3D
printing
techniques
have
limited
capacity
to
produce
composite
biomaterials
with
multi-scale
resolution.
Volumetric
bioprinting
recently
emerged
as
a
paradigm-shift
biofabrication.
This
ultrafast,
light-based
technique
sculpts
cell-laden
hydrogel
bioresins
into
structures
layerless
fashion,
providing
enhanced
design
freedom
over
conventional
bioprinting.
it
yields
prints
low
mechanical
stability,
since
soft,
cell-friendly
hydrogels
are
used.
Herein,
possibility
converge
volumetric
melt
electrowriting,
which
excels
at
patterning
microfibers,
is
shown
for
fabrication
tubular
hydrogel-based
composites
behavior.
Despite
including
non-transparent
electrowritten
scaffolds
process,
high-resolution
bioprinted
successfully
achieved.
Tensile,
burst,
and
bending
properties
printed
tubes
tuned
altering
mesh
design,
resulting
multi-material
constructs
customizable,
anisotropic
geometries
that
better
mimic
intricate
biological
structures.
As
proof-of-concept,
engineered
obtained
by
building
trilayered
vessels,
features
(valves,
branches,
fenestrations)
can
be
rapidly
using
this
hybrid
approach.
multi-technology
convergence
offers
new
toolbox
manufacturing
mechanically
tunable
living
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(2), P. 386 - 386
Published: Jan. 9, 2025
The
blood-brain
barrier
(BBB)
is
a
crucial
structure
that
maintains
brain
homeostasis
by
regulating
the
entry
of
molecules
and
cells
from
bloodstream
into
central
nervous
system
(CNS).
Neurodegenerative
diseases
such
as
Alzheimer's
Parkinson's
disease,
well
ischemic
stroke,
compromise
integrity
BBB.
This
leads
to
increased
permeability
infiltration
harmful
substances,
thereby
accelerating
neurodegeneration.
In
this
review,
we
explore
mechanisms
underlying
BBB
disruption,
including
oxidative
stress,
neuroinflammation,
vascular
dysfunction,
loss
tight
junction
integrity,
in
patients
with
neurodegenerative
diseases.
We
discuss
how
breakdown
contributes
neurotoxicity,
abnormal
accumulation
pathological
proteins,
all
which
exacerbate
neuronal
damage
facilitate
disease
progression.
Furthermore,
potential
therapeutic
strategies
aimed
at
preserving
or
restoring
function,
anti-inflammatory
treatments,
antioxidant
therapies,
approaches
enhance
integrity.
Given
role
neurodegeneration,
maintaining
its
represents
promising
approach
slow
prevent
progression
Frontiers in Neuroendocrinology,
Journal Year:
2022,
Volume and Issue:
65, P. 100989 - 100989
Published: March 8, 2022
Prevalence
of
mental
disorders,
including
major
depressive
disorder
(MDD),
bipolar
(BD)
and
schizophrenia
(SZ)
are
increasing
at
alarming
rates
in
our
societies.
Growing
evidence
points
toward
sex
differences
these
conditions,
high
treatment
resistance
support
the
need
to
consider
novel
biological
mechanisms
outside
neuronal
function
gain
mechanistic
insights
that
could
lead
innovative
therapies.
Blood-brain
barrier
alterations
have
been
reported
MDD,
BD
SZ.
Here,
we
provide
an
overview
sex-specific
immune,
endocrine,
vascular
transcriptional-mediated
changes
affect
neurovascular
integrity
possibly
contribute
pathogenesis
disorders.
We
also
identify
pitfalls
current
literature
highlight
promising
biomarkers.
Better
understanding
how
adaptations
can
health
status
is
essential
not
only
context
SZ
but
cardiovascular
diseases
stroke
which
associated
with
higher
prevalence
conditions.
Cell Proliferation,
Journal Year:
2022,
Volume and Issue:
55(4)
Published: Feb. 21, 2022
The
purpose
of
this
study
was
to
investigate
the
treatment
effect
and
molecular
mechanism
tetrahedral
framework
nucleic
acids
(tFNAs),
novel
self-assembled
acid
nanomaterials,
in
diffuse
BMEC
injury
after
SAH.tFNAs
were
synthesized
from
four
ssDNAs.
effects
tFNAs
on
SAH-induced
explored
by
a
cytotoxicity
model
induced
hemin,
breakdown
product
hemoglobin,
vitro
mouse
SAH
via
internal
carotid
artery
puncture
vivo.
Cell
viability
assays,
wound
healing
transwell
tube
formation
assays
performed
explore
cellular
function
like
angiogenesis.In
demonstrated
that
could
alleviate
hemin-induced
injury,
promote
angiogenesis,
inhibit
apoptosis
hemin
model.
In
vivo
using
H&E
TEM
results
jointly
indicated
attenuate
damage
caused
situ,
showing
restored
number
BMECs
endothelium
layer
more
tight
intercellular
connectivity.
Histological
examination
animals
confirmed
study,
as
exhibited
against
cerebral
microvascular
bed.Our
suggests
potential
ameliorating
SAH,
which
laid
theoretical
foundation
for
further
use
these
nanomaterials
tissue
engineering
vascularization.
European Journal of Nuclear Medicine and Molecular Imaging,
Journal Year:
2022,
Volume and Issue:
50(4), P. 1051 - 1083
Published: Nov. 28, 2022
Abstract
The
blood–brain
barrier
(BBB)
is
the
interface
between
central
nervous
system
and
systemic
circulation.
It
tightly
regulates
what
enters
removed
from
brain
parenchyma
fundamental
in
maintaining
homeostasis.
Increasingly,
BBB
recognised
as
having
a
significant
role
numerous
neurological
disorders,
ranging
acute
disorders
(traumatic
injury,
stroke,
seizures)
to
chronic
neurodegeneration
(Alzheimer’s
disease,
vascular
dementia,
small
vessel
disease).
Numerous
approaches
have
been
developed
study
vitro,
vivo,
ex
vivo.
complex
multicellular
structure
effects
of
disease
are
difficult
recreate
accurately
functional
aspects
cannot
be
easily
studied
As
such,
value
vivo
methods
intact
overstated.
This
review
discusses
function
how
these
affected
diseases.
then
depth
several
established
novel
for
imaging
with
focus
on
MRI,
nuclear
imaging,
high-resolution
intravital
fluorescence
microscopy.
European journal of medical research,
Journal Year:
2024,
Volume and Issue:
29(1)
Published: Jan. 3, 2024
Abstract
Early
diagnosis
and
pharmacological
treatment
of
central
nervous
system
(CNS)
diseases
has
been
a
long-standing
challenge
for
clinical
research
due
to
the
presence
blood–brain
barrier.
Specific
proteins
RNAs
in
brain-derived
extracellular
vesicles
(EVs)
usually
reflect
corresponding
state
brain
disease,
therefore,
EVs
can
be
used
as
diagnostic
biomarkers
CNS
diseases.
In
addition,
engineered
fused
target
cells
delivery
cargo,
demonstrating
great
potential
nanocarrier
platform.
We
review
progress
markers
drug
carriers
neurological
The
main
areas
include
visual
imaging,
biomarker
loading
therapy
different
types
It
is
hoped
that
increased
knowledge
will
facilitate
their
translation
Molecules,
Journal Year:
2025,
Volume and Issue:
30(2), P. 333 - 333
Published: Jan. 15, 2025
Epilepsy
is
a
chronic
neurological
disorder
that
affects
nearly
50
million
people
worldwide.
Experimental
evidence
suggests
epileptic
neurons
are
linked
to
the
endocannabinoid
system
and
inhibition
of
FAAH
enzyme
could
have
neuroprotective
effects
by
increasing
levels
endogenous
anandamide.
In
this
context,
use
macamides
as
therapeutic
agents
in
diseases
has
increased
recent
years.
With
similar
structure
anandamide,
several
theories
point
FAAH-macamide
interaction
possible
cause
enzymatic
inhibition.
work,
we
used
silico
vivo
techniques
analyze
potential
effect
three
synthetic
treatment
epilepsy:
N-3-methoxybenzyl-oleamide
(3-MBO),
N-3-methoxybenzyl-linoleamide
(3-MBL),
N-3-methoxybenzyl-linolenamide
(3-MBN).
first
stage,
an
analysis
was
conducted
explore
energetic
affinity
these
with
rFAAH
their
inhibitory
effect.
MD
simulations,
molecular
docking,
MM/PBSA
calculations
were
for
purposes.
Based
on
our
results,
selected
two
best
performed
study
male
Sprague
Dawley
rat
models.
Rats
subjected
induction
status
intraperitoneal
injection
pilocarpine
analyzed
according
Racine
scale.
results
showed
"plugging"
membrane
access
channel
active
site
On
other
hand,
anticonvulsant
both
macamides,
3-MBL
being
most
active,
resulting
higher
survival
probability
rats.
This
work
represents
one
studies
epilepsy.
Biomolecules,
Journal Year:
2025,
Volume and Issue:
15(3), P. 340 - 340
Published: Feb. 27, 2025
Methamphetamine
(METH)
is
a
powerful
addictive
psychostimulant
that
gives
rise
to
severe
abusers
worldwide.
While
many
studies
have
reported
on
the
neurotoxicity
of
METH,
blood–brain
barrier
(BBB)
dysfunction
has
recently
attracted
attention
as
an
essential
target
in
METH-induced
pathological
changes
brain.
However,
its
mechanism
not
been
fully
understood.
We
found
METH
increased
paracellular
permeability
and
decreased
vascular
integrity
through
FITC–dextran
trans-endothelial
electrical
resistance
(TEER)
assay
primary
human
brain
endothelial
cells
(HBMECs).
Also,
redistribution
tight
junction
proteins
(zonula
occluden-1
claudin-5)
reorganization
F-actin
cytoskeleton
were
observed
METH-exposed
HBMECs.
To
determine
BBB
disruption,
RhoA/ROCK
signaling
pathway
was
examined
METH-treated
METH-activated
RhoA,
followed
by
increase
phosphorylation
downstream
effectors,
myosin
light
chain
(MLC)
cofilin,
occurs
Pretreatment
with
ROCK
inhibitors
Y-27632
fasudil
reduced
MLC
preventing
cytoskeletal
reorganization.
Moreover,
leakage
alleviated
vitro
vivo.
Taken
together,
these
results
suggest
induces
activating
pathway,
which
via
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Dec. 16, 2022
In
the
past
two
years,
world
has
faced
pandemic
caused
by
severe
acute
respiratory
syndrome
2
coronavirus
(SARS-CoV-2),
which
August
of
2022
infected
around
619
million
people
and
death
6.55
individuals
globally.
Although
SARS-CoV-2
mainly
affects
tract
level,
there
are
several
reports,
indicating
that
other
organs
such
as
heart,
kidney,
pancreas,
brain
can
also
be
damaged.
A
characteristic
observed
in
blood
serum
samples
patients
suffering
COVID-19
disease
moderate
stages,
is
a
significant
increase
proinflammatory
cytokines
interferon-α
(IFN-α),
interleukin-1β
(IL-1β),
interleukin-2
(IL-2),
interleukin-6
(IL-6)
interleukin-18
(IL-18),
well
presence
autoantibodies
against
interferon-λ
(IFN-λ),
C-C
motif
chemokine
ligand
26
(CCL26),
CXC
12
(CXCL12),
family
with
sequence
similarity
19
(chemokine
(C-C
motif)-like)
member
A4
(FAM19A4),
1
(CCL1).
Interestingly,
it
been
described
chronic
cytokinemia
related
to
alterations
blood-brain
barrier
(BBB)
permeability
induction
neurotoxicity.
Furthermore,
generation
processes
neurogenesis,
neuronal
repair,
chemotaxis
optimal
microglia
function.
These
observations
support
notion
who
survived
present
neurological
sequelae
neuropsychiatric
disorders.
The
goal
this
review
explore
relationship
between
inflammatory
humoral
immune
markers
major
damage
manifested
post-COVID-19
patients.